Home
PCRX
PCRX News

Latest Pacira BioSciences Inc. (PCRX) News on December 23, 2024

Here's Why Pacira (PCRX) is a Strong Momentum Stock

Zacks

4 days ago

Here's Why Pacira (PCRX) is a Strong Momentum Stock

Argus Research

5 days ago

PCRX: What does Argus have to say about PCRX?

DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc.

PR Newswire

11 days ago

DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc.

Argus Research

12 days ago

PCRX: Raising target price to $16.00

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

16 days ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Argus Research

19 days ago

PCRX: What does Argus have to say about PCRX?

Pacira Awarded New U.S. Patent Covering EXPAREL Composition

GlobeNewswire

19 days ago

Pacira Awarded New U.S. Patent Covering EXPAREL Composition

Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term

Zacks

23 days ago

Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term

Argus Research

a month ago

PCRX: What does Argus have to say about PCRX?

Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

GlobeNewswire

a month ago

Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

Argus Research

a month ago

PCRX: Lowering target price to $13.00

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

GlobeNewswire

a month ago

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 11/11/2024

Argus Research

a month ago

Daily – Vickers Top Insider Picks for 11/08/2024

Pacira Q3 Earnings Top, Revenues Miss Despite Exparel Sales Growth

Zacks

a month ago

Pacira Q3 Earnings Top, Revenues Miss Despite Exparel Sales Growth

Thomson Reuters StreetEvents

a month ago

Q3 2024 Pacira Biosciences Inc Earnings Call

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/07/2024

Pacira BioSciences Inc (PCRX) Q3 2024 Earnings Call Highlights: Strong Financial Position ...

GuruFocus.com

2 months ago

Pacira BioSciences Inc (PCRX) Q3 2024 Earnings Call Highlights: Strong Financial Position ...

Associated Press Finance

2 months ago

Pacira: Q3 Earnings Snapshot

Pacira BioSciences Reports Third Quarter 2024 Financial Results

GlobeNewswire

2 months ago

Pacira BioSciences Reports Third Quarter 2024 Financial Results

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/06/2024

Argus Research

2 months ago

PCRX: What does Argus have to say about PCRX?

Pacira BioSciences Inc (PCRX) Q3 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

2 months ago

Pacira BioSciences Inc (PCRX) Q3 2024: Everything You Need To Know Ahead Of Earnings

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/05/2024

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings

GlobeNewswire

2 months ago

Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/04/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 11/01/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/31/2024

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024

GlobeNewswire

2 months ago

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/30/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/29/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/28/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/25/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/24/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/23/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/22/2024

Are Options Traders Betting on a Big Move in Pacira BioSciences (PCRX) Stock?

Zacks

2 months ago

Are Options Traders Betting on a Big Move in Pacira BioSciences (PCRX) Stock?

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

GlobeNewswire

2 months ago

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/21/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/18/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/17/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/16/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/15/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/14/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/11/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/10/2024

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/09/2024

Argus Research

2 months ago

PCRX: Raising target price to $13.00

Argus Research

2 months ago

Daily – Vickers Top Insider Picks for 10/08/2024

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

3 months ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/07/2024

The three-year loss for Pacira BioSciences (NASDAQ:PCRX) shareholders likely driven by its shrinking earnings

Simply Wall St.

3 months ago

The three-year loss for Pacira BioSciences (NASDAQ:PCRX) shareholders likely driven by its shrinking earnings

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/04/2024

Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025

GlobeNewswire

3 months ago

Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/03/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/02/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 10/01/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/30/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/27/2024

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

GlobeNewswire

3 months ago

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/26/2024

DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders

PR Newswire

3 months ago

DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/25/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/24/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/23/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/20/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/19/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/18/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/17/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/16/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/13/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/12/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/11/2024

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/10/2024

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

3 months ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

3 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Argus Research

3 months ago

Daily – Vickers Top Insider Picks for 09/09/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/06/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/05/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/04/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 09/03/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 08/30/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 08/29/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 08/28/2024

Argus Research

4 months ago

PCRX: Lowering target price to $12.00

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 08/27/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 08/26/2024

Argus Research

4 months ago

Daily – Vickers Top Insider Picks for 08/23/2024

Argus Research

4 months ago

PCRX: Rating decreased to a SELL

Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey

GlobeNewswire

4 months ago

Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

4 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Pacira BioSciences, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Simply Wall St.

5 months ago

Pacira BioSciences, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Pacira (PCRX) Q2 Earnings Beat, Exparel Sales Drive Revenues

Zacks

5 months ago

Pacira (PCRX) Q2 Earnings Beat, Exparel Sales Drive Revenues

Associated Press Finance

5 months ago

Pacira: Q2 Earnings Snapshot

Pacira BioSciences Reports Second Quarter 2024 Financial Results

GlobeNewswire

5 months ago

Pacira BioSciences Reports Second Quarter 2024 Financial Results

Argus Research

5 months ago

PCRX: Lowering target price to $21.00

Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024

GlobeNewswire

5 months ago

Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024

Nanotechnology in medicine: Who are the leading public companies?

Medical Device Network

5 months ago

Nanotechnology in medicine: Who are the leading public companies?

Should Value Investors Buy Pacira BioSciences (PCRX) Stock?

Zacks

5 months ago

Should Value Investors Buy Pacira BioSciences (PCRX) Stock?

Argus Research

5 months ago

PCRX: What does Argus have to say about PCRX?

Share on Social Networks: